Logo American Journal of Case Reports

Call: 1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo American Journal of Case Reports Logo American Journal of Case Reports Logo American Journal of Case Reports

13 July 2020: Articles  Saudi Arabia

Desmoplastic Small Round Cell Tumor of Pancreatic Origin in a Young Child: A Case Report and Review of Literature

Challenging differential diagnosis, Management of emergency care, Patient complains / malpractice, Rare disease, Adverse events of drug therapy , Clinical situation which can not be reproduced for ethical reasons

Daniyah Saleh A , Sahar Al-Maghrabi A , Haneen Al-Maghrabi A , Jaudah Al-Maghrabi A*

DOI: 10.12659/AJCR.922762

Am J Case Rep 2020; 21:e922762



BACKGROUND: Desmoplastic small round cell tumor (DSRCT) is a rare lethal malignant tumor with young male predominance. The majority of cases arise in the abdominopelvic region and are hypothesized to have a mesothelial origin. However, extra-abdominal and extraperitoneal DSRCT have been reported. It is extremely uncommon for the pancreas to be a primary site for DSRCT, and only 5 cases have previously been reported in the English literature. Clinically, DSRCT has a wide range of presentations from asymptomatic to life-threatening comorbidity, and it responds poorly to treatment despite aggressive therapy.

CASE REPORT: We report a previously healthy 9-year-old boy with an incidentally discovered abdominal mass of pancreatic origin. All necessary laboratory investigations were within normal limits. Computed tomographic imaging showed a huge left-side retroperitoneal mass measuring 15 cm in the greatest dimension that was accompanied by vascular encasement. The mass was resected successfully. Histopathological examination along with ancillary tests favored a diagnosis of DSRCT over other small round blue cell tumors. Detection of translocation t(11;22)(p13;q12) with EWSR1-WT1 gene fusion, based on reverse transcription-polymerase chain reaction analysis, confirmed the diagnosis. Approximately 7 months later, the tumor recurred with mesenteric lymph nodes metastasis and the child was placed on palliative therapy.

CONCLUSIONS: It is worthwhile to consider DSRCT in the differential diagnosis of small round blue cell tumors, even in unusual sites, in a pediatric age group. Due to the poor prognosis, owing to chemotherapy resistance and a high rate of recurrence with significant tumor burden, reaching a precise diagnosis of DSRCT is essential. Almost all cases harbor the hallmark molecular alteration of t(11;22)(p13;q12) with EWSR1-WT1 gene fusion. Debulking surgery paired with a chemotherapy regimen comprising vincristine, doxorubicin, and cyclophosphamide and ifosfamide + etoposide has been shown to improve overall survival rate compared with other chemotherapeutic agents. However, no targeted therapeutic modality has been developed.

Keywords: desmoplastic small round cell tumor, Pancrelipase, Pediatrics, Child, Incidental Findings, Lymphatic Metastasis, Male, Neoplasm Recurrence, Local, Oncogene Proteins, Fusion, Pancreatic Neoplasms, RNA-Binding Protein EWS, Translocation, Genetic


In 1989, desmoplastic small round cell tumor (DSRCT) was recognized as a separate entity by Gerald and Rosai [1]. This rare malignant tumor predominantly affects children and adolescent males, with a peak incidence in the third decade of life [2]. Usually, it arises from serosal surfaces, mainly the peritoneum. The second most common site is the abdominopelvic region, with no distinct organ involvement. However, DSRCT arising from various body organs, such as pleura, ovary, testis, central nervous system, orbit, and others, has been described [3,4]. Primary pancreatic DSRCT is extremely rare, limited only to 5 reported cases in the available English literature (Table 1). Since DSRCT has nonspecific imaging features, microscopic examination is very helpful because it shows malignant cells with primitive morphology of undifferentiated round blue cells separated by the cellular desmoplastic stromal reaction. In addition, immunohistochemistry expression of mixed mesenchymal, epithelial, and neural markers is exclusively supportive. The most accurate, well-established molecular analysis is by reverse transcription-polymerase chain reaction (RT-PCR) or fluorescence in situ hybridization (FISH), which identify translocation t(11;22)(p13;q12) with EWSR1-WT1 gene fusion. A modality of combined surgery, chemotherapy, and radiotherapy is the mainstay of management. In general, DSRCT behaves aggressively and is associated with very poor prognosis. Hence, proper identification of DSRCT is of great value. Herein, we describe a rare case of DSRCT originating from the pancreas in an asymptomatic child.

Case Report

A previously healthy 9-year-old boy presented to a pediatric surgery clinic with a history of abdominal mass accompanied by intermittent abdominal pain during the 3 months before admission. The mass was incidentally discovered at an outside facility after the boy experienced a mild abdominal trauma. Physical examination demonstrated firmness on the left side of the abdomen. Otherwise, the child was alert and in good general condition. Laboratory investigations, including blood profile, renal and liver function tests, coagulation profile, electrolytes, and urine analysis, were within normal limits. Amylase was 165 U/L and lipase was 259 U/L; tumor markers were not performed. Abdominal computed tomography (CT) scan with contrast showed a left flank soft tissue abdominal mass (15×10.1×6.5 cm) that extended from the splenic hilum down to the level of the aorta bifurcation. The mass was associated with significant vascular encasement, and it was not separable from the pancreatic body and tail. No definite hepatic or splenic lesions were present (Figure 1A). Radiological impression included neuroblastoma, lymphoma, and neuroendocrine tumor. The patient underwent exploratory laparotomy for debulking and removal of the tumor with distal pancreatectomy, splenectomy, splenic flexure, and colon segment resection. Microscopic examination depicted an infiltrative neoplastic growth arranged in well-defined, relatively sharply demarcated nests embedded in the dense desmoplastic stroma. The neoplastic cells exhibited features of small round blue cells with increased nuclear to stromal ratio, hyperchromatic nuclei, and scarce cytoplasm (Figure 1B, 1C). To reach a specific diagnostic entity, a panel of immunohistochemistry markers were assayed. Neoplastic cells were immunoreactive to vimentin, desmin (Figure 1D), CD56 (Figure 1E), CD57, and neuron-specific enolase (Figure 1F). They showed focal positivity for EMA, SMA, CD15, and CD99. A few cells showed weak staining for CK8/18. Assays were negative for pan-cytokeratin, MSA, myogenin, Myo-D1, chromogranin, synaptophysin, CD34, CD31, CD117, and CA19-9. Tumor staining for WT-1 was inconclusive. The aforementioned tumor morphology along with the immunophenotype raised our suspicion for DSRCT. A molecular study for t(11;22) EWSR1-WT1 gene fusion using RT-PCR was conducted at the Mayo Clinic. The result confirmed our diagnosis of DSRCT arising from the pancreas. There is no specific tumor marker for DSRCT. The patient completed 6 cycles of chemotherapy using the non-rhabdomyosarcoma protocol including ifosfamide, doxorubicin, and vincristine with a 3-week interval between each cycle for 15 weeks. Seven months later, the patient appeared severely ill with marked deterioration, and a recurrence of the mass was suspected. Imaging was not available, and he underwent another exploratory laparotomy for resection of the recurred mass and dissection of mesenteric lymph nodes. Histopathological examination showed morphology identical to the initial DSRCT consistent with recurrence and metastasis. The patient was placed on palliative treatment to improve his quality of life and to increase the symptom-free survival time through disease stabilization. He was also provided with psychological and social support.


DSRCT is an uncommon sarcomatous neoplasm with a young male predilection. Most of the reported cases were found to arise in the pelvic and intra-abdominal region [5]. Although the most common site is the peritoneum, extraperitoneal DSRCT has been described in various body organs, such as the parotid gland, ovary, testis, and pleura, and orbit [2–4]. To the best of our knowledge, only 5 reported cases have described DSRCT in the pancreas as a predominant intra-abdominal solid organ involvement [6–10] (Table 1). Individuals with DSRCT present with various clinical presentations, from asymptomatic to a complex large intra-abdominal mass manifested as abdominal pain or symptoms of compression. Only one previously reported case included painful obstructive jaundice [8]. Our case is interesting as the mass was discovered incidentally after mild abdominal trauma. It subsequently progressed rapidly, and it was found to arise from the pancreas. It adhered to the spleen, splenic flexure, and part of the colon, which required aggressive surgical removal through exploratory laparotomy. In this case, the pancreas was almost replaced by the tumor. The distal part was involved initially, followed by involvement of the head of the pancreas. However, there was no evidence of pelvic, omental, or peritoneal deposits or ascites, which made a primary peritoneal DSRCT with invasion to the pancreas less likely. Histopathologic features of this tumor helped to reach the diagnosis. The malignant cells exhibited features of primitive cells with scant cytoplasm and hyperchromatic nuclei with inconspicuous nucleoli. They were arranged in variable histologic patterns and formed tubules or nests encircled by dense desmoplastic fibro-myxoid stroma. The diagnosis of this tumor is challenging in children, even with known polyphenotypic immunohistochemistry markers, because it does not have a specific radiological image and it may show various types of differentiation such as epithelial, mesenchymal, or neuronal [11]. Characteristically, DSRCT expresses desmin in a dot-like pattern, as in our case, and nuclear positivity for WT-1 along with immunoreactivity for an epithelial component favors DSRCT over other small round blue cell tumors. Unfortunately, WT-1 was inconclusive in our case. However, the current case was negative for myogenin and MyoD1, which made rhabdomyosarcoma unlikely. In addition, the negativity for chromogranin and synaptophysin helped to rule out the possibility of neuroendocrine tumors. At the time, Ewing sarcoma/PNET could not be completely excluded due to focal membranous positivity for a highly sensitive marker, CD99. However, CD99 is not specific, and many other small round blue cell tumors may express it. The diagnosis of DSRCT was confirmed by detecting a characteristic cytogenetic abnormality of gene fusion between the EWSR1 gene on chromosome 22 and the WT1 gene on chromosome 11, which is expressed as t(11;22)(p13;q12), using RT-PCR. Conversely, Ewing sarcoma/PNET has a unique reciprocal translocation t(11;22)(q24; q12) between the EWSR1 and FLI1 genes. DSRCT possesses aggressive behavior and poor prognosis, with a median survival rate of 17 months (range 3–72) [8]. Hence, its recognition is of extreme importance. The tumor in our patient recurred with metastasis to mesenteric lymph nodes 7 months after removal of the initial mass and 6 cycles of chemotherapy of non-rhabdomyosarcoma protocol. There are no known differences between the typical versus pancreatic DSRCT. To date, there is no targeted therapy for DSRCT, but a combination of surgical debulking; chemotherapy using a high-dose P6 regimen including doxorubicin, cyclophosphamide, and vincristine; and radiotherapy results in a better impact on the stability of the disease. Alternatively, ifosfamide and etoposide regimen may be used [12]. The 3-and 5- year survival rates in patients with DSRCT have been documented to be 44% and 15%, respectively [12].


Despite the rarity cases of DSRCT, even in the classic abdominopelvic cavity, several studies have documented DSRCT arising in a different body organs including the pancreas. Considering DSRCT within the continuum of differential diagnoses of small round blue cell tumors, particularly in extraperitoneal locations, is beneficial. However, there are no known significant differences between pancreatic compared with primary peritoneal DSRCT. Reaching a precise diagnosis of DSRCT is essential because the behavior and management of this neoplasm may differ markedly. In challenging cases, the characteristic trans-location and fusion gene (EWSR1-WT1) can be exploited for diagnosis even in unusual sites.


1.. Gerald WL, Rosai J: Pediatr Pathol, 1989; 9; 177-83

2.. Hatanaka KC, Takakuwa E, Hatanaka Y: Diagn Pathol, 2019; 14(1); 43

3.. Kretschmar CS, Colbach C, Bhan I, Crombleholme TM: J Paediatr Hematol Oncol, 1996; 18; 293-98

4.. He XR, Liu Z, Wei J: Int Ophthalmol, 2019; 39; 471-75

5.. Gil A, Portilla AG, Brun EA, Sugarbaker PH: Oncology, 2004; 67; 231-42

6.. Bismar TA, Basturk O, Gerald WL: Am J Surg Pathol, 2004; 28; 808-12

7.. Seshadri A, Arora A, Agrawal N, Chattopaddhaya TK: Pancreatology, 2014; 14; S4

8.. Subasinghe D, Keppetiyagama CT, Sudasinghe H: JOP, 2014; 15; 618-21

9.. Qureshi S, Shrikhande S, Ramadwar M: J Indian Assoc Pediatr Surg, 2011; 16; 66-68

10.. Ryan A, Razak A, Graham J: J Clin Oncol, 2007; 25(11); 1440-42

11.. Kim JW, Park JH, Cho HJ: Cancer Res Treat, 2009; 41; 233-36

12.. Bulbul A, Fahy BN, Xiu J: Sarcoma, 2017; 2017; 1278268


19 May 2022 : Case report  Serbia

Bilateral Emphysematous Pyelonephritis Associated with COVID Pneumonia: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.936370  

17 May 2022 : Case report  USA

High-Frequency Oscillatory Ventilation for Refractory Hypoxemia in Severe COVID-19 Pneumonia: A Small Case ...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936651  

13 May 2022 : Case report  Japan

A case of exacerbation of haloperidol-induced rhabdomyolysis following the onset of COVID-19

Am J Case Rep In Press; DOI: 10.12659/AJCR.936589  

13 May 2022 : Case report  USA

Acute Disseminated Encephalomyelitis After SARS-CoV-2 Vaccination

Am J Case Rep In Press; DOI: 10.12659/AJCR.936574  

In Press

20 May 2022 : Case report  Canada

Diagnostic Puzzle of Acute Ischemic Stroke Mimics – Seizure Versus Post-Stroke Recrudescence: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.936826  

19 May 2022 : Case report  Saudi Arabia

Extremes of Anemia: The Lowest Hemoglobin Values Probably Ever Reported in the Pediatric Literature Attribu...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936252  

19 May 2022 : Case report  Brazil

Acute Hepatitis with Positive Autoantibodies: A Case of Natalizumab-Induced Early-Onset Liver Injury

Am J Case Rep In Press; DOI: 10.12659/AJCR.936318  

19 May 2022 : Case report  Japan

Successful Percutaneous Fogarty Thrombectomy for Subacute Lower Limb Ischemia Due to Resistant Thrombus in ...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936377  

Most Viewed Current Articles

31 Dec 1969 : Case report  USA

Penile Necrosis Associated with Local Intravenous Injection of Cocaine

DOI :10.12659/AJCR.935250

Am J Case Rep 2022; 23:e935250

31 Dec 1969 : Case report  Oman

Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of P...

DOI :10.12659/AJCR.934399

Am J Case Rep 2022; 23:e934399

31 Dec 1969 : Case report  Brazil

Lipedema Can Be Treated Non-Surgically: A Report of 5 Cases

DOI :10.12659/AJCR.934406

Am J Case Rep 2021; 22:e934406

31 Dec 1969 : Case report  USA

A Rare Case of Coronavirus Disease 2019 Vaccine-Associated Cerebral Venous Sinus Thrombosis Treated with Me...

DOI :10.12659/AJCR.935355

Am J Case Rep 2022; 23:e935355

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

American Journal of Case Reports eISSN: 1941-5923
American Journal of Case Reports eISSN: 1941-5923